Literature DB >> 23636656

Diffusion tensor imaging (DTI) and its clinical correlates in drug naïve Wilson's disease.

Rakesh Jadav1, Jitender Saini, Sanjib Sinha, Bhavanishankara Bagepally, S Rao, Arun B Taly.   

Abstract

The purpose is to evaluate white matter (WM) abnormalities in Wilson's disease (WD) using the technique of diffusion tensor imaging (DTI). The prospective case-control study comprised of 15 drug-naïve patients with WD and 15 controls. The phenotype of subjects was evaluated. The DTI/conventional MRI was acquired (3T MRI): Fractional anisotropy (FA) and mean diffusivity (MD) values were extracted from regions of interest placed in pons, midbrain, bilateral frontal and occipital cerebral white matter, bilateral internal capsules (IC), middle cerebellar peduncles (MCP) and corpus callosum (CC). Six patients showed lobar WM signal changes on T(2)-Weighted (T2W)/Fluid attenuation inversion recovery (FLAIR) images while remaining had normal appearing WM. MD was significantly increased in the lobar WM, bilateral IC and midbrain of WD patients. FA was decreased in the frontal and occipital WM, bilateral IC, midbrain and pons. Normal-appearing white matter on FLAIR images showed significantly increased MD and decreased FA values in both frontal and occipital lobar WM and IC compared with those in controls. Correlation of clinical scores and DTI metrics revealed positive correlation between neurological symptom score (NSS) and MD of anterior limb of right internal capsule, Chu stage and MD of frontal and occipital WM. Negative correlation was observed between the Modified Schwab and England Activities of Daily Living (MSEADL) score and MD of bilateral frontal and occipital WM and IC. This is the probably the first study to reveal widespread alterations in WM by DTI metrics in drug naïve WD. DTI analysis revealed lobar WM abnormalities which is less frequently noted on conventional MRI and suggests widespread WM abnormalities in WD. It may be valuable in assessing the true extent of involvement and therefore the severity of the illness.

Entities:  

Mesh:

Year:  2013        PMID: 23636656     DOI: 10.1007/s11011-013-9407-1

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  24 in total

1.  Diffusion MRI findings in Wilson's disease.

Authors:  R N Sener
Journal:  Comput Med Imaging Graph       Date:  2003       Impact factor: 4.790

2.  Wilson's disease: cranial MRI observations and clinical correlation.

Authors:  S Sinha; A B Taly; S Ravishankar; L K Prashanth; K S Venugopal; G R Arunodaya; M K Vasudev; H S Swamy
Journal:  Neuroradiology       Date:  2006-06-03       Impact factor: 2.804

3.  Cognitive profile and structural findings in Wilson's disease: a neuropsychological and MRI-based study.

Authors:  Shantala Hegde; Sanjib Sinha; Shobini L Rao; Arun B Taly; M K Vasudev
Journal:  Neurol India       Date:  2010 Sep-Oct       Impact factor: 2.117

Review 4.  Wilson's disease.

Authors:  Aftab Ala; Ann P Walker; Keyoumars Ashkan; James S Dooley; Michael L Schilsky
Journal:  Lancet       Date:  2007-02-03       Impact factor: 79.321

5.  Proton MR spectroscopy in Wilson disease: analysis of 36 cases.

Authors:  Leandro T Lucato; Maria Concepción G Otaduy; Egberto R Barbosa; Alexandre A C Machado; Alexander McKinney; Luiz A Bacheschi; Milberto Scaff; Giovanni G Cerri; Claudia C Leite
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

6.  Distribution of cerebral lesions in acquired hepatocerebral degeneration.

Authors:  M H Finlayson; B Superville
Journal:  Brain       Date:  1981-03       Impact factor: 13.501

7.  Neurological impairment and recovery in Wilson's disease: evidence from PET and MRI.

Authors:  G Schlaug; H Hefter; V Engelbrecht; T Kuwert; S Arnold; G Stöcklin; R J Seitz
Journal:  J Neurol Sci       Date:  1996-03       Impact factor: 3.181

8.  Sequential MRI changes in Wilson's disease with de-coppering therapy: a study of 50 patients.

Authors:  S Sinha; A B Taly; L K Prashanth; S Ravishankar; G R Arunodaya; M K Vasudev
Journal:  Br J Radiol       Date:  2007-08-20       Impact factor: 3.039

9.  Cognitive functioning in neurologically symptomatic and asymptomatic forms of Wilson's disease.

Authors:  Joanna Seniów; Thomas Bak; Jolanta Gajda; Renata Poniatowska; Anna Czlonkowska
Journal:  Mov Disord       Date:  2002-09       Impact factor: 10.338

Review 10.  Diagnosis and treatment of Wilson's disease.

Authors:  G J Brewer; J K Fink; P Hedera
Journal:  Semin Neurol       Date:  1999       Impact factor: 3.420

View more
  11 in total

Review 1.  Neurologic impairment in Wilson disease.

Authors:  Petr Dusek; Tomasz Litwin; Anna Członkowska
Journal:  Ann Transl Med       Date:  2019-04

2.  Improvement of Diffusion Tensor Imaging (DTI) Parameters with Decoppering Treatment in Wilson's Disease.

Authors:  A Lawrence; J Saini; S Sinha; S Rao; M Naggappa; P S Bindu; A B Taly
Journal:  JIMD Rep       Date:  2015-06-30

3.  Altered large-scale functional brain networks in neurological Wilson's disease.

Authors:  Rixing Jing; Yongsheng Han; Hewei Cheng; Yongzhu Han; Kai Wang; Daniel Weintraub; Yong Fan
Journal:  Brain Imaging Behav       Date:  2020-10       Impact factor: 3.978

4.  Structural and Functional Changes Are Related to Cognitive Status in Wilson's Disease.

Authors:  Sheng Hu; Chunsheng Xu; Ting Dong; Hongli Wu; Yi Wang; Anqin Wang; Hongxing Kan; Chuanfu Li
Journal:  Front Hum Neurosci       Date:  2021-02-25       Impact factor: 3.169

5.  Study on Lesion Assessment of Cerebello-Thalamo-Cortical Network in Wilson's Disease with Diffusion Tensor Imaging.

Authors:  Anqin Wang; Hongli Wu; Chunsheng Xu; Lanfeng Tang; Jaeyoun Lee; Min Wang; Man Jiang; Chuanfu Li; Qi Lu; Chunyun Zhang
Journal:  Neural Plast       Date:  2017-07-11       Impact factor: 3.599

6.  Microstructure changes in whiter matter relate to cognitive impairment in Wilson's disease.

Authors:  Ting Dong; Wen-Ming Yang; Ming-Cai Wu; Juan Zhang; Peng Huang; Chun-Sheng Xu; An-Qin Wang; Chun-Jun Kuang; Zhi-Ling Gao
Journal:  Biosci Rep       Date:  2019-03-15       Impact factor: 3.840

7.  Injury factors and pathological features of toxic milk mice during different disease stages.

Authors:  Xiang-Xue Zhou; Xun-Hua Li; Ding-Bang Chen; Chao Wu; Li Feng; Hao-Lin Qin; Xiao-Yong Pu; Xiu-Ling Liang
Journal:  Brain Behav       Date:  2019-11-19       Impact factor: 2.708

8.  Oromandibular Dystonia in Wilson's Disease.

Authors:  Jayantee Kalita; Abhay Ranjan; Usha K Misra
Journal:  Mov Disord Clin Pract       Date:  2015-05-09

9.  The asymmetry of neural symptoms in Wilson's disease patients detecting by diffusion tensor imaging, resting-state functional MRI, and susceptibility-weighted imaging.

Authors:  Xiang-Xue Zhou; Xun-Hua Li; Ding-Bang Chen; Chao Wu; Li Feng; Jian-Ping Chu; Zhi-Yun Yang; Xin-Bei Li; Haolin Qin; Gui-Dian Li; Hai-Wei Huang; Ying-Ying Liang; Xiu-Ling Liang
Journal:  Brain Behav       Date:  2018-04-14       Impact factor: 2.708

10.  Aberrant Coupling Between Resting-State Cerebral Blood Flow and Functional Connectivity in Wilson's Disease.

Authors:  Sheng Hu; Hongli Wu; ChunSheng Xu; Anqin Wang; Yi Wang; Tongping Shen; Fangliang Huang; Hongxing Kan; Chuanfu Li
Journal:  Front Neural Circuits       Date:  2019-04-18       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.